Francesco Massari

80PUBLICATIONS
128CO-AUTHORS
Surface water quality processes and contaminated sediment assessmentMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (80)

|May 27, 2026
Microplastics as both a driver of genitourinary cancers and a deliverer of treatments.

|Jan 20, 2026
New insights into Nectin-4 expression in testicular choriocarcinoma and its potential treatment with Enfortumab Vedotin: analysis of a multi-institutional series and association with clinical-pathological features.

Costantino Ricci, Luisa Di Sciascio, Francesca Ambrosi

|Jan 07, 2026
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study.

Thomas Büttner, Mimma Rizzo, Laura Bernal Vaca

|Oct 29, 2025
Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 Study.

Francesco Massari, Matteo Rosellini, Bohuslav Melichar

|Sep 19, 2025
Immunohistochemical expression of EZH2 in germ cell tumors of the testis: New insights into the genesis and epigenetic reprogramming of these fascinating tumors.

Sofia Melotti, Francesca Ambrosi, Tania Franceschini

|Sep 11, 2025
Immunohistochemical expression of Nectin-4 and potential implications for enfortumab vedotin therapy in germ cell tumors of the testis: a preliminary study.

Costantino Ricci, Francesca Ambrosi, Tania Franceschini

Pageof 14

Frequent Collaborators

26 joint publications

Veronica Mollica

22 joint publications

Alessandro Rizzo

15 joint publications

Michelangelo Fiorentino

13 joint publications

Alessia Cimadamore